Blog

Vilchis Tree Services Pro Celebrates Hispanic Heritage and Community Unity Through Acworth Concert on The Green

October 17, 2025 – PRESSADVANTAGE –

Vilchis Tree Services Pro has published a new blog post highlighting the recent Hispanic Heritage Month Concert in Acworth, GA. The article, titled “Hispanic Heritage Month Concert Brings Acworth, GA Together,” focuses on the city’s cultural unity and the meaningful connections built through shared community celebrations. The post underscores the company’s ongoing commitment to celebrating diversity, fostering local engagement, and supporting initiatives that bring residents closer together.

The blog reflects Vilchis Tree Services Pro’s belief that a thriving community grows stronger when its members come together with shared respect and pride. The company’s marketing director, Alex Laldin, emphasized this message in his remarks, stating, “Community is at the heart of everything we do. This concert wasn’t just a celebration of Hispanic heritage it was a celebration of what makes Acworth special. People from all backgrounds came together to enjoy great music, food, and company. It showed how unity creates strength and how cultural appreciation enriches our lives.”

The concert served as a reminder of Acworth’s inclusive spirit. Families, friends, and local businesses participated in a day filled with music, dance, and authentic cuisine. The blog captures the event’s atmosphere and expresses appreciation for the organizers who worked hard to make the celebration memorable. Vilchis Tree Services Pro takes pride in being part of a community that values culture, tradition, and togetherness.

Laldin continued, “We’ve always believed that business and community go hand in hand. Supporting local events like this helps build trust, connection, and shared purpose. Our team lives and works in this community, so being involved means a lot to us. We want to highlight the positive energy that events like the Hispanic Heritage Month Concert bring to Acworth.”

The post also discusses how local gatherings create opportunities for small businesses to engage with their neighbors and give back. For Vilchis Tree Services Pro, this type of engagement is more than just participation it’s a reflection of their values. The company continues to show support for local causes and events that bring people together in meaningful ways.

Throughout the blog, readers gain insight into the company’s belief that growth extends beyond professional success. It is about developing relationships and maintaining respect for the people who make up the local area. Laldin noted, “Our company is built on service, reliability, and trust, but we know those things are rooted in strong relationships. Every time we take part in an event like this, it reminds us why community involvement matters. It keeps us connected to the people we serve.”

The Hispanic Heritage Month Concert offered residents a chance to celebrate cultural contributions that have shaped the region’s character. From live performances to local vendors, the event symbolized the power of shared experiences. The blog captures that spirit and encourages readers to continue supporting events that celebrate cultural diversity.

Vilchis Tree Services Pro’s dedication to the Acworth area extends beyond its professional services. The company consistently seeks ways to uplift and contribute to the local community. Laldin shared, “We see every job and every event as an opportunity to make a positive impact. Whether we’re providing tree care services or highlighting important community events, our goal is to help our city thrive.”

Through its latest blog post, Vilchis Tree Services Pro encourages readers to recognize the importance of cultural celebrations and the unity they foster. The company believes that acknowledging shared heritage brings people together and inspires pride in the community. The blog concludes by emphasizing that events like the Hispanic Heritage Month Concert serve as a bridge between generations and cultures, strengthening the foundation of Acworth’s identity.

As Vilchis Tree Services Pro continues to serve Acworth and surrounding areas, the company remains committed to being a reliable service provider and an active community supporter. Laldin summarized this vision by saying, “Our business depends on people’s trust. That trust grows when we invest in our community. We want to continue celebrating events like these that make Acworth a better place for everyone.”

Vilchis Tree Services Pro is a professional tree care company serving Acworth, Georgia, and nearby communities. The company provides expert services including tree removal, trimming, pruning, stump grinding, and emergency tree care. With a focus on safety, precision, and customer satisfaction, Vilchis Tree Services Pro delivers dependable solutions for residential and commercial clients. The company’s mission is to keep properties safe and healthy while maintaining the beauty of local landscapes.

Vilchis Tree Services Pro believes in building trust through honest work and community involvement. The team is committed to serving neighbors with respect and integrity while supporting events and causes that strengthen local connections. More information about the company and its services can be found at company website.

###

For more information about Vilchis Tree Services Pro of Acworth, contact the company here:

Vilchis Tree Services Pro of Acworth
Alex Laldin
(404) 868-9079
alex@steeltoedigital.com
3420 Novis Pointe NW, Acworth, GA 30101

October 24, 2025
Inland Cosmetic Surgery Announces Week of Beauty Patient Appreciation Event

RANCHO CUCAMONGA, CA – October 20, 2025 – PRESSADVANTAGE –

Rancho Cucamonga-based Inland Cosmetic Surgery announced it will host a “Week of Beauty” patient appreciation event from October 20-24, 2025, featuring both virtual educational sessions and an in-person evening event designed to provide aesthetic treatment education and patient recognition. The week-long program will include daily virtual webinars and conclude with a ticketed appreciation event on Thursday, October 23, 2025.

Practice director and cosmetic surgeon Dr. Jacob Haiavy, MD, FACS, explained the educational focus behind the event. “This event represents our commitment to patient education and appreciation,” said Dr. Haiavy. “We designed the Week of Beauty to provide comprehensive information about aesthetic treatments while recognizing the trust our patients place in our practice. Patient education has always been fundamental to our approach to aesthetic medicine.”

The event will begin with virtual educational webinars titled “The Beauty Soirée: Virtual Edition” running Monday through Friday at 12:30 PM and 7:00 PM Pacific Time. These sessions will feature live demonstrations of non-surgical procedures and educational content about aesthetic treatment options available at the practice. The virtual format allows patients throughout the region and beyond to participate regardless of scheduling constraints or geographic location.

“Patient education remains central to everything we do,” explained Dr. Emma Ryan, DO, who practices alongside Dr. Haiavy at the Rancho Cucamonga facility. “These webinar sessions provide detailed information about treatment processes, patient selection criteria, and realistic expectations for various aesthetic procedures. Our goal is ensuring patients have the comprehensive information needed to make informed decisions about their care.”

The educational webinars will cover topics including advanced injection techniques, laser therapy applications, and non-surgical body contouring options. Each session will include dedicated time for patient questions and detailed explanations of treatment protocols. The practice’s experienced medical team will present information about safety considerations, recovery timelines, and expected outcomes for various procedures.

The week will conclude with an in-person Patient Appreciation Event on Thursday, October 23, 2025, from 6:00 PM to 8:00 PM at the practice’s main location at 8680 Monroe Court, Rancho Cucamonga, CA 91730. The ticketed event, priced at $50, will include educational presentations, networking opportunities with the medical team, and a question-and-answer session with both cosmetic surgeons.

“The in-person event creates an opportunity for direct interaction between patients and our clinical team in a relaxed educational environment,” said Dr. Haiavy. “Attendees will receive detailed information about treatment options, participate in educational discussions, and connect with other patients who share similar aesthetic goals. This personal interaction enhances the educational experience significantly.”

The evening event will feature refreshments and educational activities designed to inform patients about the latest developments in aesthetic medicine. Attendees will have opportunities to interact with expert injectors and estheticians while learning about advanced treatment techniques and safety protocols in cosmetic procedures.

Together, Dr. Haiavy, Dr. Ryan, and the Inland Cosmetic Surgery team have performed over 30,000 procedures in a state-of-the-art, fully accredited outpatient surgery center and medical spas. The practice operates multiple locations including associated medical spas Ahava Medspa and Made You Look, serving patients throughout the Inland Empire region of Southern California.

Inland Cosmetic Surgery has established itself as a regional leader in aesthetic medicine by combining advanced treatment options with comprehensive patient education and personalized care. The practice maintains its commitment to patient safety, natural-looking results, and ongoing education about the latest developments in aesthetic medicine.

Registration for virtual webinar sessions is available through the practice website, while tickets for the Thursday evening appreciation event are limited and available for purchase online. Those interested in attending either virtual or in-person events can register by visiting the practice website or calling 909-987-0899.

###

For more information about Inland Cosmetic Surgery – Rancho Cucamonga, contact the company here:

Inland Cosmetic Surgery – Rancho Cucamonga
Dr. Jacob Haiavy
909-987-0899
maryam@inlandcosmetic.com
8680 Monroe Ct STE 200, Rancho Cucamonga, CA 91730

October 24, 2025
XCF Global Regains Compliance with Nasdaq Listing Requirements

HOUSTON, TEXAS / ACCESS Newswire / October 17, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX), a key player in decarbonizing the aviation industry through Sustainable Aviation Fuel (“SAF”), today announces that it has filed its Quarterly Report on Form 10-Q for the period ended June 30, 2025, with the U.S. Securities and Exchange Commission (“SEC”).

As a result of the filing, the company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the SEC.

The Form 10-Q is available on the SEC’s website at www.sec.gov.

About XCF Global, Inc.

XCF Global, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry’s transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is listed on the Nasdaq Capital Market and trades under the ticker, SAFX. Current outstanding shares: ~159.2 million; <20% free float (as of October 17, 2025).

To learn more, visit www.xcf.global.

Contacts

XCF Global:
C/O Camarco
XCFGlobal@camarco.co.uk

Media:

Camarco
Andrew Archer | Rosie Driscoll | Violet Wilson
XCFGlobal@camarco.co.uk

Forward Looking Statements

This Press Release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global’s expectations with respect to future performance and anticipated financial impacts of the recently completed business combination with Focus Impact BH3 Acquisition Company (the “Business Combination”), estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global’s expenses, including manufacturing and operating expenses and interest expenses, as a result of potential inflationary pressures, changes in interest rates and other factors; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global’s offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination or others; (5) XCF Global’s ability to regain compliance with Nasdaq’s continued listing standards and thereafter continue to meet Nasdaq’s continued listing standards; (6) XCF Global’s ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global’s ability to raise financing to fund its operations and business plan and the terms of any such financing; (8) the New Rise Reno production facility’s ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) the New Rise Reno production facility’s ability to produce renewable diesel in commercial quantities without interruption during the ongoing SAF ramp-up process; (10) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its landlord with respect to the ground lease for the New Rise Reno facility; (11) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (12) payment of fees, expenses and other costs related to the completion of the Business Combination and the New Rise acquisitions; (13) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (14) XCF Global’s ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (15) changes in applicable laws or regulations; (16) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (17) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (18) the availability of tax credits and other federal, state or local government support; (19) risks relating to XCF Global’s and New Rise’s key intellectual property rights, including the possible infringement of their intellectual property rights by third parties; (20) the risk that XCF Global’s reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (21) the effects of increased costs associated with operating as a public company; and (22) various factors beyond management’s control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global’s filings with the Securities and Exchange Commission (“SEC”), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global made or will make with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global’s expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global’s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.

SOURCE: XCF Global, Inc.

View the original press release on ACCESS Newswire

October 23, 2025
Unusual Machines Appoints Jason Reels as Vice President of Supply Chain

Reels to strengthen operational execution and expand U.S.-based manufacturing capacity for defense and enterprise markets

ORLANDO, FLORIDA / ACCESS Newswire / October 20, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant drone components, today announced the appointment of Jason Reels as Vice President of Supply Chain. Reels will report to Chief Operating Officer Andrew Camden and lead Unusual Machines’ global supply chain operations as the company expands production capacity across its U.S. facilities.

Reels will oversee inbound logistics, materials management, and fulfillment to improve speed, coordination, and throughput as the company scales motor and headset production to meet growing defense and enterprise demand.

“Operating a disciplined and efficient supply chain is the backbone of our ability to deliver,” said Andrew Camden, COO of Unusual Machines. “Jason’s experience leading complex logistics networks and scaling production across multiple regions will strengthen our execution as we continue expanding domestic manufacturing.”

Reels brings more than 15 years of experience across the automotive, manufacturing, and technology sectors, building multi-site supply chains in North America, Mexico, and Asia, and implementing ERP and warehouse systems aligned with NetSuite. His background supports Unusual Machines’ continued emphasis on reliability, compliance, and speed within its production network.

“We’re building for scale in a way that keeps control and quality front and center,” said Jason Reels. “I’m focused on building the systems and teams that keep production moving at the speed our customers have come to expect from Unusual Machines.”

About Unusual Machines

Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.

For more information, please visit www.unusualmachines.com.

Investor Contact

CS Investor Relations
investors@unusualmachines.com

Media Contact

media@unusualmachines.com

SOURCE: Unusual Machines, Inc.

View the original press release on ACCESS Newswire

October 23, 2025

Geotechnical Drilling Starts at Central Gawler Mill

Results to inform detailed TSF1 mine design, schedule and costs

ADELAIDE, AU / ACCESS Newswire / October 22, 2025 / Barton Gold Holdings Limited (ASX:BGD)(OTCQB:BGDFF)(FRA:BGD3) (Barton or the Company) is pleased to confirm that geotechnical drilling has started in support of a recently launched Definitive Feasibility Study for ‘Stage 1′ production (Stage 1 DFS) at the Company’s South Australian Challenger Gold Project (Challenger).¹

The planned program includes 5 sonic drilling holes to recover TSF1 materials for laboratory testing, 24 holes for Cone Penetration Testing (CPTu) and further laboratory testing, and 3 holes for push tube density testing.

The program is expected to take three weeks to complete, with the results to inform the dry recovery of TSF1 tailings materials, detailed mine design, a mining schedule and estimate of mining costs for the Stage 1 DFS.

Figure 1 – Cross section showing higher-grade peripheral TSF1 materials & 0.7g/t Au grade shell¹

Commenting on the start of geotechnical drilling, Barton Managing Director Alexander Scanlon said:

“With the Stage 1 DFS now underway, we are excited to kick off the first of several production-related work programs that will inform key elements of mine design, scheduling, equipment selection and operating costs for tailings recovery.

“Following a $15m placement led by Franklin Templeton, Barton is well funded to advance the restart of operations at its Central Gawler Mill, with approximately $20m cash in the bank and credit financing discussions underway.

“We are now on the road to production, leveraging our fully permitted Central Gawler Mill to operations and growth. This is an invaluable stepping stone for our vision to become South Australia’s largest independent gold producer.”

Authorised by the Managing Director of Barton Gold Holdings Limited.

For further information, please contact:

Alexander Scanlon
Managing Director
a.scanlon@bartongold.com.au
+61 425 226 649

Jade Cook
Company Secretary
cosec@bartongold.com.au
+61 8 9322 1587

About Barton Gold
Barton Gold is an ASX, OTCQB and Frankfurt Stock Exchange listed Australian gold developer targeting future gold production of 150,000ozpa with 2.2Moz Au & 3.1Moz Ag JORC Mineral Resources (79.9Mt @ 0.87g/t Au), brownfield mines, and 100% ownership of the region’s only gold mill in the renowned Gawler Craton of South Australia.^*

Competent Persons Statement & Previously Reported Information

The information in this announcement that relates to the historic Exploration Results and Mineral Resources as listed in the table below is based on, and fairly represents, information and supporting documentation prepared by the Competent Person whose name appears in the same row, who is an employee of or independent consultant to the Company and is a Member or Fellow of the Australasian Institute of Mining and Metallurgy (AusIMM), Australian Institute of Geoscientists (AIG) or a Recognised Professional Organisation (RPO). Each person named in the table below has sufficient experience which is relevant to the style of mineralisation and types of deposits under consideration and to the activity which he has undertaken to quality as a Competent Person as defined in the JORC Code 2012 (JORC).

Activity	Competent Person	Membership	Status
Tarcoola Mineral Resource (Stockpiles)	Dr Andrew Fowler (Consultant)	AusIMM	Member
Tarcoola Mineral Resource (Perseverance Mine)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Tarcoola Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tarcoola Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tunkillia Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Mineral Resource	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (above 215mRL)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (below 90mRL)	Mr Dale Sims	AusIMM / AIG	Fellow / Member
Wudinna Mineral Resource (Clarke Deposit)	Ms Justine Tracey	AusIMM	Member
Wudinna Mineral Resource (all other Deposits)	Mrs Christine Standing	AusIMM / AIG	Member / Member

The information relating to historic Exploration Results and Mineral Resources in this announcement is extracted from the Company’s Prospectus dated 14 May 2021 or as otherwise noted in this announcement, available from the Company’s website at www.bartongold.com.au or on the ASX website www.asx.com.au. The Company confirms that it is not aware of any new information or data that materially affects the Exploration Results and Mineral Resource information included in previous announcements and, in the case of estimates of Mineral Resources, that all material assumptions and technical parameters underpinning the estimates, and any production targets and forecast financial information derived from the production targets, continue to apply and have not materially changed. The Company confirms that the form and context in which the applicable Competent Persons’ findings are presented have not been materially modified from the previous announcements.

Cautionary Statement Regarding Forward-Looking Information

This document may contain forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “expect”, “target” and “intend” and statements than an event or result “may”, “will”, “should”, “would”, “could”, or “might” occur or be achieved and other similar expressions. Forward-looking information is subject to business, legal and economic risks and uncertainties and other factors that could cause actual results to differ materially from those contained in forward-looking statements. Such factors include, among other things, risks relating to property interests, the global economic climate, commodity prices, sovereign and legal risks, and environmental risks. Forward-looking statements are based upon estimates and opinions at the date the statements are made. Barton undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such dates or to update or keep current any of the information contained herein. Any estimates or projections as to events that may occur in the future (including projections of revenue, expense, net income and performance) are based upon the best judgment of Barton from information available as of the date of this document. There is no guarantee that any of these estimates or projections will be achieved. Actual results will vary from the projections and such variations may be material. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. Any reliance placed by the reader on this document, or on any forward-looking statement contained in or referred to in this document will be solely at the readers own risk, and readers are cautioned not to place undue reliance on forward-looking statements due to the inherent uncertainty thereof.

¹Refer to ASX announcement dated 29 September 2025

^* Refer to Barton Prospectus dated 14 May 2021 and ASX announcement dated 8 September 2025. Total Barton JORC (2012) Mineral Resources include 1,049koz Au (39.7Mt @ 0.82 g/t Au) in Indicated category and 1,186koz Au (40.2Mt @ 0.92 g/t Au) in Inferred category, and 3,070koz Ag (34.5Mt @ 2.80 g/t Ag) in Inferred category as a subset of Tunkillia gold JORC (2012) Mineral Resources.

SOURCE: Barton Gold Holdings Limited

View the original press release on ACCESS Newswire

October 23, 2025

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

Company to discontinue development of mRNA-1647 in congenital CMV

Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients

Company does not anticipate any impact to its 2025 financial guidance or its expectation of achieving breakeven in 2028

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s investigational cytomegalovirus (CMV) vaccine. The study did not meet its primary efficacy endpoint of preventing CMV infection in seronegative female participants of childbearing age (16-40 years of age). Moderna will discontinue its congenital CMV clinical development program.

“Today’s announcement is disappointing for families and healthcare professionals who have been eagerly awaiting a CMV vaccine to prevent congenital CMV, a leading infectious cause of birth defects,” said Stéphane Bancel, Chief Executive Officer of Moderna. “The majority of the data from this trial is still forthcoming, and we will share our full results with the scientific community in hopes that our learnings can contribute to the continued pursuit of a CMV vaccine. I am grateful for our dedicated team, our partners at clinical trial sites, and all the trial participants who made this research possible.”

The Phase 3 trial (NCT05085366) was a randomized, observer-blind, placebo-controlled study. The study included approximately 7,500 women 16-40 years of age from approximately 300 sites across 13 countries, representing the largest trial assessing the efficacy of a CMV vaccine to-date. Vaccine efficacy against primary CMV infection in healthy women was well below the Company’s target, ranging from 6% to 23% depending on the case definition used.

“We are clearly disappointed by the failure to prevent primary infection because it means there is still no vaccine for the prevention of congenital CMV despite the many decades of work by the field,” said Stephen Hoge, MD, President of Moderna. “CMV does cause significant disease in other contexts, including reactivation of the latent virus in those undergoing bone marrow transplantation, and we will continue to explore the potential of mRNA-1647 to suppress disease associated with reactivation in those high-risk patients through our ongoing Phase 2 study.”

mRNA-1647 was found to be generally well-tolerated regardless of CMV serostatus, with a safety profile consistent with earlier studies. No safety concerns have been raised by the Data and Safety Monitoring Board. The Company plans to continue its study of mRNA-1647 in bone marrow transplant patients, which is currently in a Phase 2 trial (NCT05683457).

Moderna does not anticipate any impact to its 2025 financial guidance or its expectation of achieving breakeven in 2028. Moderna anticipated minimal initial revenue contribution from mRNA-1647 given necessary investments in market building and launch, and expected the product to be cash-flow negative in 2028.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna’s 2025 financial guidance and its expectation of achieving breakeven in 2028; and the potential of mRNA-1647 for bone marrow transplant patients and Moderna’s ongoing Phase 2 trial. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:

Chris Ridley
Head of Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:

Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

October 23, 2025
AeroGuard Flight Training Center Partners With U.S. Air Force to Train Future Pilots

PHOENIX, ARIZONA / ACCESS Newswire / October 22, 2025 / AeroGuard Flight Training Center, a leading provider of flight training with over 25 years’ experience training professional pilots, is excited to announce a new program with the United States Air Force to provide high-quality training for its student pilots. Through this agreement, AeroGuard will provide the initial flight training for Air Force pilots, equipping them with the skills, knowledge, and experience necessary to advance to the next phase of their military aviation careers.

AeroGuard Selected by U.S. Air Force to Train Future Pilots

Air Force Pilots will train at AeroGuard’s headquarters in Phoenix, Arizona, USA, where they will receive their initial flight training, obtaining their Private Pilot License with Instrument and Multi Engine Ratings. AeroGuard integrates high-quality flight training into every stage of the program, ensuring a smooth transition for pilots to advance to the next phase of their career preparation.

AeroGuard’s Phoenix, Arizona, campus offers an unparalleled training environment, providing Air Force pilots with 45,000 square feet of campus, over 360 flying days a year, diverse airspace, large standardized fleet, experienced instructors, and expansive practice areas. This ideal flight training environment provides cadets with well-rounded flight experience, instilling the skills they need to become high-quality and confident pilots.

Joel Davidson, AeroGuard CEO, shared, “AeroGuard is honored and proud to support the United States Air Force in developing its future pilots. Through this partnership, AeroGuard will provide our expertise in initial pilot training for aspiring professional aviators, while the Air Force will receive well-trained pilots fully prepared for their future military roles. Our commitment to safety, excellence, and the highest-quality pilot training seamlessly aligns with the Air Force’s mission, and we look forward to training their student pilots.”

As a leading flight training provider for airlines and universities across the globe, Air Force pilots at AeroGuard will train in a structured and professional environment, joining future airline pilots from world-leading airlines such as Cathay Pacific, Air New Zealand, and Air India, as well as hundreds of U.S. students training for their own future careers.

The first class of Air Force Officers is set to start flight training at the end of this month. AeroGuard looks forward to welcoming these officers to campus and preparing them as they grow into successful, skilled, and fully capable pilots for the United States Air Force.

About AeroGuard Flight Training Center:

AeroGuard Flight Training Center is a global leader in ab initio flight training with three U.S. campuses that offer accelerated commercial pilot training programs to candidates from all over the world. With a commitment to safety and student success, AeroGuard’s high-quality and career-focused curriculum has established airline-ready cadets for over 25 years with more than one million flight hours of training experience and graduating over 8,000 cadets.

Contact Information

James Constable
Chief Marketing Officer
jconstable@flyaeroguard.com
800-322-1526

SOURCE: Aeroguard Flight Training Center

View the original press release on ACCESS Newswire

October 23, 2025
Ketamine Therapy for Anxiety and PTSD Highlighted in Resource from Moment of Clarity

Huntington Beach, California – October 17, 2025 – PRESSADVANTAGE –

Moment of Clarity has published a new resource titled “Using Ketamine for Anxiety and PTSD Treatment“, now available on their website. The article examines how ketamine therapy may support patients living with anxiety disorders and post-traumatic stress disorder (PTSD), particularly those who have not found sufficient relief through traditional treatments. The resource aims to provide patients, families, and communities with a clear understanding of where ketamine fits within modern mental health care.

Anxiety and PTSD are among the most common mental health challenges, often accompanied by symptoms that disrupt sleep, relationships, and daily functioning. Standard therapies such as medication and counseling remain effective for many, but a significant number of patients experience treatment-resistant symptoms. The publication explains how ketamine, administered in controlled clinical settings, interacts with brain receptors linked to mood regulation and may provide rapid symptom relief. Unlike conventional antidepressants that may take weeks to show benefits, ketamine has demonstrated a faster onset in certain patients.

Research supports these observations. Studies published in JAMA Psychiatry (2019) and clinical reviews from the National Institutes of Health indicate that ketamine can reduce symptoms of depression and trauma-related conditions in some individuals who did not respond to other treatments. However, the article makes clear that while ketamine is FDA-approved as an anesthetic and esketamine (Spravato) is FDA-approved for treatment-resistant depression, the use of ketamine for anxiety and PTSD remains off-label and should only be provided under careful medical supervision.

For patients in Huntington Beach, California, the resource highlights how ketamine therapy may complement existing services such as group therapy, family counseling, and psychiatric evaluations. By reducing the intensity of acute symptoms, ketamine may allow patients to engage more effectively in talk therapy and skill-building interventions. The article emphasizes that ketamine is not a replacement for these services, but a tool that can strengthen their impact.

The publication also addresses safety. Administered in licensed medical environments, ketamine therapy is closely monitored to ensure patient well-being. Common side effects, such as dizziness or mild dissociation, are typically temporary and resolve on their own. Medical supervision ensures that dosing is carefully controlled and that patients receive support throughout each session.

Another focus is the importance of trauma-informed care. Many patients struggling with PTSD also live with co-occurring conditions such as depression or substance use disorders. The article notes that ketamine therapy is most effective when integrated into comprehensive care programs that may also include cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and medication management. This integrative approach reflects a commitment to addressing both the biological and psychological aspects of recovery.

Moment of Clarity’s resource also acknowledges the stigma that can surround advanced therapies. Some patients hesitate to explore newer treatments due to fear of judgment or misconceptions about them. By providing evidence-informed explanations of ketamine’s role, the publication seeks to normalize the use of innovative therapies alongside established methods, encouraging earlier access to care.

Continuity of care is another central theme. While ketamine therapy may provide rapid relief, the resource emphasizes that lasting recovery depends on ongoing therapeutic engagement. Patients may begin with ketamine sessions but require continued counseling, family therapy, and psychiatric evaluations to build resilience and maintain progress over time.

By publishing Using Ketamine for Anxiety and PTSD Treatment, Moment of Clarity reinforces its role as a trusted provider of patient education. The article explains how ketamine therapy works, clarifies its regulatory status, reviews emerging research, and highlights its potential integration into broader treatment plans.

For individuals in Huntington Beach and the surrounding area seeking reliable information on advanced mental health options, this resource offers balanced, research-based guidance. By combining education with clinical expertise, Moment of Clarity in Huntington Beach helps patients and families explore innovative recovery pathways while maintaining confidence in the safety and effectiveness of their care.

###

For more information about Moment of Clarity Huntington Beach, contact the company here:

Moment of Clarity Huntington Beach
Marie Mello
(949) 403-6740
marie@momentofclarity.com

October 23, 2025
WhiteSands Releases New Guide Answering: How To Recognize the Early Signs of Vicodin Addiction

CLEARWATER, FL – October 17, 2025 – PRESSADVANTAGE –

WhiteSands Alcohol & Drug Rehab Clearwater has released a new online resource titled “Understanding the Signs of Vicodin Addiction“, available on their website. The article offers families and patients practical insight into identifying early warning signs of opioid misuse, the risks associated with Vicodin, and the importance of timely access to supervised withdrawal care.

The publication highlights that Vicodin, a prescription medication often used for pain relief, carries a high potential for dependence when misused. Many people may not recognize the gradual shift from prescribed use to abuse until physical and psychological symptoms are already present. The article outlines key indicators such as behavioral changes, mood swings, and withdrawal effects as important signals that medical attention is necessary. By presenting this information in clear terms, WhiteSands aims to shorten the time between the onset of symptoms and seeking treatment.

The resource underscores that opioid addiction is a medical condition, not a personal weakness. Patients who attempt to stop using Vicodin without clinical guidance often encounter intense withdrawal symptoms, including nausea, muscle pain, anxiety, and insomnia. These symptoms can quickly lead to relapse if detox is attempted outside a supervised setting. Drawing on findings from the Substance Abuse and Mental Health Services Administration (SAMHSA), the article explains that medically supported detox programs improve patient safety and increase the likelihood of successful recovery.

WhiteSands Clearwater emphasizes the importance of supervised detoxification as the foundation for effective addiction treatment. The center provides 24/7 monitoring in medically supported environments, along with access to medication-assisted protocols that ease discomfort and reduce risks during withdrawal. Detox alone, however, is not sufficient for long-term recovery. Once patients stabilize, they are encouraged to transition into comprehensive care programs that address the psychological and behavioral drivers of addiction through inpatient or outpatient therapy, relapse prevention strategies, and long-term recovery planning.

The article also explains the importance of integrating detox with evidence-based counseling. Detox clears the body of substances, but therapy addresses the underlying issues that fuel addiction. Combining these approaches ensures patients begin recovery with both physical stability and a plan for emotional and mental health support. Research from the National Institute on Drug Abuse (NIDA) is cited, noting that treatment outcomes are stronger when detoxification is followed by structured therapy and ongoing support services.

Financial accessibility is another factor addressed in the resource. The article highlights the value of treatment programs that strike a balance between affordability and clinical quality, noting that cost concerns often deter families from seeking help. By encouraging patients and their loved ones to explore programs that provide both safety and cost-effective care, WhiteSands aims to reduce the barriers that prevent people from pursuing treatment.

Local context is acknowledged throughout the publication, with attention given to the needs of Clearwater residents and the surrounding areas. Whether in coastal neighborhoods like Clearwater Beach or smaller nearby communities, the challenges of opioid misuse remain consistent: families often struggle to recognize when prescription use has become dependency, and patients may delay care until the addiction is advanced. The resource seeks to address this gap in awareness by offering guidance that is both medically accurate and accessible to all patients.

The article concludes by stressing the urgency of early intervention. Delays in addressing Vicodin misuse can lead to worsening dependence, health complications, and increased risk of overdose. By making information available online, WhiteSands aims to reach families at the critical point when questions first arise about whether a loved one may be struggling with opioid misuse.

For people searching for “drug rehab near me” or “medication-assisted detox in Clearwater,” this resource provides clear, evidence-based information rather than promotional promises. It is designed to help families make informed decisions, emphasizing that recovery begins with recognizing the signs and taking action promptly.

With the release of Understanding the Signs of Vicodin Addiction, WhiteSands Alcohol & Drug Rehab reinforces its role as both a treatment provider and an educational resource. By focusing on the warning signs of opioid misuse and the importance of supervised detox, the center continues its mission to support patients and families with compassion, clinical expertise, and a commitment to long-term recovery.

###

For more information about WhiteSands Alcohol & Drug Rehab Clearwater, contact the company here:

WhiteSands Alcohol & Drug Rehab Clearwater
Ryan Monesson
(727) 270-9970
rmonesson@wstreatment.com
1932 Drew St, Clearwater, FL 33765

October 23, 2025
SMX Tightens Its Core as the World Moves Toward Its Proof-Based Economy (NASDAQ: SMX)

NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Every investor knows the reflex. You see the words reverse split, and your instincts flinch. It’s practically Pavlovian. But sometimes, what looks like retreat is actually recalibration. And that’s exactly what’s happening at SMX (NASDAQ:SMX). The company that made “proof” a product and traceability a trillion-dollar opportunity just tightened its capital structure in a move that could position it for an entirely different kind of growth.

As of October 23, 2025, SMX’s recap will take effect, consolidating approximately 15.5 million ordinary shares into about one million. The math may look surgical, but the intent is strategic. This isn’t a desperate act of survival; it’s a precision tune-up for a company that’s been quietly building the digital backbone of global commerce.

Re-engineering the Foundation

Let’s cut through the noise. A reverse split doesn’t change a company’s fundamentals. What it does change is perception-and for SMX, perception has always been a powerful asset. The move tightens the float, raises the share price, and signals confidence that the company’s valuation story is far from over. It’s the kind of restructuring that clears static from the air, giving the real story room to breathe.

That story, by the way, is massive. SMX’s molecular marker technology is redefining authenticity, transforming physical goods into verifiable digital assets-proof instead of promise. Whether it’s plastics, metals, textiles, or electronics, the company’s system can permanently encode a material’s origin, lifecycle, and legitimacy.

This isn’t theory; it’s traction. SMX’s ecosystem already includes partnerships with Singapore’s A*STAR, CETI in France, Tradepro Group, BT-Systems and REDWAVE in Europe, NAFRA and AsureQuality in Australia, and even collaborative initiatives extending into defense and critical minerals supply chains. Add to that its ongoing work with BASF and Continental, and you begin to see a network that’s not just expanding, but compounding in influence. SMX isn’t just participating in global traceability-it’s defining it.

While others react to regulation, SMX is quietly building the infrastructure regulators will rely on. That’s not survival-it’s strategy.

A Cap Structure Built for Momentum

So why consolidate now? Because timing is everything. The reduction in outstanding shares creates a leaner, more investable structure-one that institutions can actually take a position in without tripping over penny-stock stigma. It’s also the first real sign that management is thinking two moves ahead, not just about survival, but about scalability.

SMX’s balance sheet now looks like a spring-loaded platform: compact, simplified, and ready for lift. With fewer shares on the table, each incremental achievement-new project, new geography, new validation-will have a more meaningful impact on per-share value. It’s the market’s equivalent of tightening your core before the next climb.

Proof Still Pays

Investors who’ve been around long enough know that markets often misread these moments. They see consolidation as contraction. In reality, it’s preparation. SMX isn’t trying to look bigger; it’s getting stronger. Its partnerships are multiplying across continents, its Plastic Cycle Token is evolving into the value layer of circular commerce, and its proof-based verification model is becoming the global standard for sustainability.

Reverse split or not, the business trajectory is unmistakable: up.

SMX has always been about transforming invisible data into visible truth-and now, it’s doing the same with its capital structure. What investors should see isn’t a shrinking chart, but a sharpening silhouette. Because when the foundation is this strong, consolidation isn’t a warning sign. It’s the prelude to acceleration.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

October 23, 2025